Starpharma Holdings Ltd
ASX:SPL
Starpharma Holdings Ltd
Cash from Investing Activities
Starpharma Holdings Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Starpharma Holdings Ltd
ASX:SPL
|
Cash from Investing Activities
-AU$156k
|
CAGR 3-Years
1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
3%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Investing Activities
AU$473.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Investing Activities
-AU$211.5m
|
CAGR 3-Years
-3 179%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-171%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Investing Activities
-AU$16.7m
|
CAGR 3-Years
-902%
|
CAGR 5-Years
-332%
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Investing Activities
-AU$14.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Investing Activities
AU$3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Starpharma Holdings Ltd's Cash from Investing Activities?
Cash from Investing Activities
-156k
AUD
Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Cash from Investing Activities amounts to -156k AUD.
What is Starpharma Holdings Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
3%
Over the last year, the Cash from Investing Activities growth was 86%. The average annual Cash from Investing Activities growth rates for Starpharma Holdings Ltd have been 1% over the past three years , 12% over the past five years , and 3% over the past ten years .